We are live on
!
Find out more
PLC
Peapod Lane Capital Portfolio holdings
AUM
$148M
1-Year Est. Return
89.92%
This Fund
S&P 500
This Quarter
Est. Return
+12.48%
1 Year Est. Return
+89.92%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$99.9M
AUM Growth
+$11M
(+12%)
Cap. Flow
+$3.03M
Cap. Flow
% of AUM
3.04%
Top 10 Holdings %
Top 10 Hldgs %
35.87%
Holding
66
New
5
Increased
41
Reduced
11
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Limoneira
LMNR
|
+$1.95M |
| 2 |
NNDM
Nano Dimension
NNDM
|
+$1.09M |
| 3 |
Twin Disc
TWIN
|
+$1.01M |
| 4 |
Acacia Research
ACTG
|
+$974K |
| 5 |
CLDT
Chatham Lodging
CLDT
|
+$937K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMRX
Chimerix, Inc.
CMRX
|
+$3.57M |
| 2 |
Geospace Technologies
GEOS
|
+$1.13M |
| 3 |
THRD
Third Harmonic Bio
THRD
|
+$777K |
| 4 |
Rafael Holdings
RFL
|
+$629K |
| 5 |
Westwood Holdings Group
WHG
|
+$588K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.05% |
| 2 | Consumer Discretionary | 19.4% |
| 3 | Industrials | 16.01% |
| 4 | Real Estate | 10.61% |
| 5 | Consumer Staples | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Alto Neuroscience
ANRO
$1.11B
| $613K | 0.61% |
+278,857
| New | +$664K |
|
52
Scholastic
SCHL
$753M
| $563K | 0.56% |
26,848
+91
| +0.3% | +$1.66K |
|
|
KZR
53
DELISTED
Kezar Life Sciences
KZR
| $527K | 0.53% |
115,123
-9,304
| -7% | -$39.9K |
|
54
Northern Technologies International Corp
NTIC
$77.7M
| $486K | 0.49% |
+65,611
| New | +$501K |
|
55
PMV Pharmaceuticals
PMVP
$62.9M
| $480K | 0.48% |
452,682
-36,688
| -7% | -$36K |
|
|
WHWK
56
Whitehawk Therapeutics
WHWK
$232M
| $453K | 0.45% |
242,210
+807
| +0.3% | +$1.41K |
|
57
Oramed Pharmaceuticals
ORMP
$179M
| $191K | 0.19% |
84,779
-167,445
| -66% | -$369K |
|
|
IMA
58
ImageneBio Inc
IMA
$63.9M
| – | – |
-24,703
| Closed | -$379K |
|
|
KE
59
Kimball Electronics
KE
$635M
| – | – |
-31,569
| Closed | -$519K |
|
60
Kodiak Sciences
KOD
$2.84B
| – | – |
-71,418
| Closed | -$200K |
|
|
KRON
61
DELISTED
Kronos Bio
KRON
| – | – |
-564,572
| Closed | -$466K |
|
62
Nektar Therapeutics
NKTR
$2.48B
| – | – |
-38,483
| Closed | -$393K |
|
63
NextCure
NXTC
$22.7M
| – | – |
-22,120
| Closed | -$127K |
|
|
64
Rafael Holdings
RFL
$105M
| – | – |
-341,103
| Closed | -$629K |
|
|
THRD
65
DELISTED
Third Harmonic Bio
THRD
| – | – |
-223,865
| Closed | -$777K |
|
|
CMRX
66
DELISTED
Chimerix, Inc.
CMRX
| – | – |
-419,696
| Closed | -$3.57M |
|
Similar funds
AWA
MM
OCM
CWMS
FFS
KCM
DAC
WC
Peapod Lane Capital's Q2 2025 Portfolio in Review
As of Q2 2025, Peapod Lane Capital held 66 positions worth $99.9M, up 12% from $88.9M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Peapod Lane Capital deployed $3.03M of net new capital in Q2 2025, opening 5 new positions and adding to 41 existing holdings. Its largest new stake was Limoneira: 123,158 shares worth $1.93M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Geospace Technologies, an estimated $1.13M trimmed.
- Peapod Lane Capital's largest Q2 2025 buy was Limoneira: 123,158 shares worth $1.93M.
- Peapod Lane Capital added most to Acacia Research in Q2 2025, an estimated $974K increase.
- Peapod Lane Capital's biggest Q2 2025 reduction was Geospace Technologies, cutting an estimated $1.13M.
- Peapod Lane Capital fully exited Chimerix, Inc. in Q2 2025, selling an estimated $3.57M.
- Peapod Lane Capital's ten largest holdings make up 36% of its $99.9M portfolio in Q2 2025.
- Peapod Lane Capital opened 5 new positions and closed 9 in Q2 2025.
- Peapod Lane Capital's portfolio value rose 12% quarter-over-quarter to $99.9M.
Based on Peapod Lane Capital's 13F filing for Q2 2025, filed 31 Jul 2025.